AG

AVICT Global Holdings

Description

An investment firm.

Investor Profile

AVICT Global Holdings has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A rounds (top funding stages).
  • Majority of deals are located in China.
  • Strong thematic focus on Biotechnology, Health Care, Oncology.

Stage Focus

  • Series A (100%)

Country Focus

  • China (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Oncology
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does AVICT Global Holdings frequently co-invest with?

Kington Capital
Asia, Jiangsu, China, Suzhou
Co-Investments: 1
Temasek Holdings
Asia, Central Region, Singapore, Singapore
Co-Investments: 1
WuXi AppTec
Asia, Shanghai, China, Shanghai
Co-Investments: 1
YuanMing Capital
Asia, Beijing, China, Haidian
Co-Investments: 1
HongShan
Asia, Beijing, China, Beijing
Co-Investments: 1
Oriza Seed Capital (Oriza Yuandian)
Asia, Jiangsu, China, Suzhou
Co-Investments: 1
Juno Therapeutics
North America, Washington, United States, Seattle
Co-Investments: 1

What are some of recent deals done by AVICT Global Holdings?

JW Therapeutics

Shanghai, Shanghai, China

JW Therapeutics is a developer of cell-based therapy technologies created to revolutionize cancer treatment.

BiotechnologyHealth CareOncologyTherapeutics
Series AMar 7, 2018
Amount Raised: $90,000,000

Find More Investors Like AVICT Global Holdings

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

AVICT Global Holdings | Pipeseed